Thymoma: Difference between revisions
| Line 44: | Line 44: | ||
[[Thymoma medical therapy|Medical therapy]] | [[Thymoma surgery|Surgical options]] | [[Thymoma primary prevention|Primary prevention]] | [[Thymoma secondary prevention|Secondary prevention]] | [[Thymoma cost-effectiveness of therapy|Financial costs]] | [[Thymoma future or investigational therapies|Future therapies]] | [[Thymoma medical therapy|Medical therapy]] | [[Thymoma surgery|Surgical options]] | [[Thymoma primary prevention|Primary prevention]] | [[Thymoma secondary prevention|Secondary prevention]] | [[Thymoma cost-effectiveness of therapy|Financial costs]] | [[Thymoma future or investigational therapies|Future therapies]] | ||
==Prognosis== | ==Prognosis== | ||
Revision as of 18:53, 18 January 2012
For patient information click here.
| Thymoma | |
 | |
|---|---|
| Thymoma: A bottle-shaped tumor is encapsulated and shows a bulging, rather homogeneous, faintly lobulated ivory-colored cut surface. Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology | |
| ICD-10 | C37.9, D60 |
| ICD-9 | 164.0, 212.6 |
| ICD-O: | 8580 |
| DiseasesDB | 13067 |
| MedlinePlus | 001086 |
| MeSH | D013945 |
|
Thymoma Microchapters |
|
Diagnosis |
|---|
|
Case Studies |
|
Thymoma On the Web |
|
American Roentgen Ray Society Images of Thymoma |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Michael Maddaleni, B.S.
Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic:
There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Historical Perspective
Pathophysiology
Epidemiology & Demographics
Risk Factors
Screening
Causes
Differentiating Thymoma
Complications & Prognosis
Diagnosis
History and Symptoms | Physical Examination | Staging | Laboratory tests | Electrocardiogram | X Rays | CT | MRI Echocardiography or Ultrasound | Other images | Alternative diagnostics
Treatment
Medical therapy | Surgical options | Primary prevention | Secondary prevention | Financial costs | Future therapies
Prognosis
Thymomas associated with autoimmune disorders usually are benign. Malignant thymomas can metastasize, generally to pleura, kidney, bone, liver or brain.[1]
Epidemiology
Men and women are equally affected. The typical age at diagnosis is 30-40, although cases have been described in every age group.[1]